# Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs

> **NCT00005673** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 46 (—)

## Conditions studied

- Healthy
- HIV Infection

## Interventions

- **DRUG:** Capravirine

## Key facts

- **NCT ID:** NCT00005673
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2002-05
- **Target enrollment:** 46 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005673, "Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00005673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*